From professional translators, enterprises, web pages and freely available translation repositories.
rilpivirínu.
by tipranavir/r.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
auc rilpivirínu ↑ 39
rilpivirine auc ↑ 39%
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
victrelisu alebo rilpivirínu
victrelis or rilpivirine is
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
režim s obsahom rilpivirínu
rilpivirine-containing regimen
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
toxicity rilpivirínu a eventuálne aj
atazanavir/ritonavir and induction
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
očakáva sa zvýšená expozícia rilpivirínu.
increased exposure of rilpivirine is expected.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lieky, ktoré ovplyvňujú expozíciu rilpivirínu
medicinal products that affect rilpivirine exposure
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
lieky, ktoré sú ovplyvnené užívaním rilpivirínu
medicinal products that are affected by the use of rilpivirine
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
2 nežiaduca reakcia identifikovaná pri hydrochloride rilpivirínu.
2 adverse reaction identified for rilpivirine hydrochloride.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nie je potrebná úprava dávky daklinzy ani rilpivirínu.
no dose adjustment of daklinza or rilpivirine is required.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zmeny sérového kreatinínu v režimoch s obsahom rilpivirínu
changes in serum creatinine for rilpivirine-containing regimens
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
konečný polčas eliminácie rilpivirínu je približne 45 hodín.
the terminal elimination half-life of rilpivirine is approximately 45 hours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokinetika rilpivirínu sa neskúmala u pacientov s obličkovou nedostatočnosťou.
the pharmacokinetics of rilpivirine have not been studied in patients with renal insufficiency.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pôsobenie rilpivirínu je sprostredkované nekompetitívnou inhibíciou rt hiv-1.
rilpivirine activity is mediated by non-competitive inhibition of hiv-1 rt.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
jedna tableta edurant obsahuje rilpivirinchlorid zodpovedajúci 25 mg rilpivirínu.
each tablet of edurant contains rilpivirine hydrochloride equivalent to 25 mg rilpivirine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokinetické vlastnosti rilpivirínu sa neštudovali u pacientov s renálnou insuficienciou.
the pharmacokinetics of rilpivirine have not been studied in patients with renal insufficiency.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
jedna filmom obalená tableta obsahuje rilpivirinchlorid zodpovedajúci 25 mg rilpivirínu.
each film-coated tablet contains rilpivirine hydrochloride equivalent to 25 mg rilpivirine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
nie sú k dispozícii žiadne údaje o vplyve rilpivirínu na fertilitu u ľudí.
no human data on the effect of rilpivirine on fertility are available.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
farmakokinetika rilpivirínu u pediatrických pacientov mladších ako 12 rokov je predmetom výskumu.
the pharmacokinetics of rilpivirine in paediatric patients < 12 years of age is under investigation.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
(indukcia cyp3a z dôvodu použitia vysokej dávky rilpivirínu v štúdii)
(induction of cyp3a due to high rilpivirine dose in the study)
Last Update: 2017-04-26
Usage Frequency: 1
Quality: